Search results
Showing 31 to 45 of 110 results for anticoagulation
This guideline covers diagnosing and managing atrial fibrillation in adults. It includes guidance on providing the best care and treatment for people with atrial fibrillation, including assessing and managing risks of stroke and bleeding.
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban (TA697)
Evidence-based recommendations on andexanet alfa (Ondexxya) for reversing anticoagulation form apixaban or rivaroxaban in adults with life-threatening or uncontrolled bleeding.
The effect of COVID-19 related lockdown on patients taking warfarin
are tested at their GP surgery they may not have any contact with the anticoagulation team regarding such issues We noted that pre COVID...
Safe and effective management of stroke prevention in atrial fibrillation
comprises of anticoagulants, with clear evidence to support the fact that anticoagulation with vitamin K antagonists (VKAs) or direct...
clinicians to Protect and Protect patients diagnosed with AF on appropriate anticoagulation therapy in line with NICE guidance, thereby...
aimed to safely manage patients according to NICE guidelines regarding anticoagulation. Patients on warfarin need tight control over...
being at high risk of stroke, based on the relevant recommendations for anticoagulation in NICE guidance for AF (NG196). This example...
performed remotely by the cardiac physiology team. If AF was detected, anticoagulation therapy was initiated without delay by the nurse...
or more, the percentage of patients who are currently treated with anticoagulation drug therapy Subject(s): Atrial fibrillation
NICE publishes updated clinical guideline on the diagnosis and management of atrial fibrillation
NICE has today (27 April 2021) published its updated guideline on the diagnosis and management of atrial fibrillation (AF).
FBC and LFTs as appropriate for their anticoagulation therapy; any adverse effects related to anticoagulation; assessment...
NICE has developed a medtech innovation briefing (MIB) on microINR for anticoagulation therapy .
Evidence-based recommendations on melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver. This involves diverting the blood flow from the liver to the rest of the body while the drug is delivered directly into the liver.
View recommendations for IPG691Show all sections
DOAC Dipstick for detecting direct oral anticoagulants (MIB248)
NICE has developed a medtech innovation briefing (MIB) on DOAC Dipstick for detecting direct oral anticoagulants .
AcQMap for mapping the heart atria to target ablation treatment for arrhythmias (MIB246)
NICE has developed a medtech innovation briefing (MIB) on AcQMap for mapping the heart atria to target ablation treatment for arrhythmias .